Insulin promotes progression of colon cancer by upregulation of ACAT1
2018 · Lipids in Health and Disease · 37 citations
https://doi.org/10.1186/s12944-018-0773-x
X
Ximing Xu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
146
Papers
2.1K
Citations
27
h-index
57
i10-index
Ximing Xu is an academic researcher from Jiangsu University. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Cancer-related molecular mechanisms research & MicroRNA in disease regulation. The author has an h-index of 27, co-authored 125 publications.
ORCID: 0000-0002-4240-5378Papers by this author
worksInsight into the Crosstalk between Photodynamic Therapy and Immunotherapy in Breast Cancer
2023 · Cancers · 25 citations
https://doi.org/10.3390/cancers15051532
An expression of squamous cell carcinoma antigen 2 in peripheral blood within the different stages of esophageal carcinogenesis
2008 · Diseases of the Esophagus · 23 citations
https://doi.org/10.1111/j.1442-2050.2007.00789.x
Platelet Membrane‐Coated Curcumin‐PLGA Nanoparticles Promote Astrocyte‐Neuron Transdifferentiation for Intracerebral Hemorrhage Treatment
2024 · Small · 20 citations
https://doi.org/10.1002/smll.202311128
ATP6V1F is a novel prognostic biomarker and potential immunotherapy target for hepatocellular carcinoma
2023 · BMC Medical Genomics · 8 citations
https://doi.org/10.1186/s12920-023-01624-6
Finotonlimab (PD-1 inhibitor) plus bevacizumab (bevacizumab biosimilar) as first-tier therapy for late-stage hepatocellular carcinoma: a randomized phase 2/3 trial
2025 · Signal Transduction and Targeted Therapy · 5 citations
https://doi.org/10.1038/s41392-025-02333-5
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat